Ginolis and FocalSpec enter value added reseller agreement

Friday, November 11, 2016 by Ginolis

Ginolis Ltd , a global desktop automation solutions provider today announced a Value Added Reseller (VAR) agreement with FocalSpec Ltd, a supplier of optical 3D surface measurement systems. The partnership facilitates the integration of FocalSpec's world leading optical measurement technology with Ginolis' automation platforms. The agreement authorizes Ginolis to sell and support the integrated systems to the medtech, medical device and diagnostics industries.

"The combination of FocalSpec' s optical measurement systems and our automation platforms are a perfect match," said Ginolis CEO Teijo Fabritius. "The regulated medical device industry demands precision and high quality. This partnership enables us to provide a broader range of products that will address those needs."

FocalSpec's Line Confocal Imaging (LCI) is a unique and globally patented measuring technology that combines the world's highest levels of accuracy with exceptional measuring speed. " FocalSpec and Ginolis are technology leaders in their respective fields," states FocalSpec President Sauli Törmälä. "Together we provide high precision solutions that allow companies to measure and test their products at manufacturing line speed."

In accordance with the agreement, Ginolis will be permitted to market, sell and support the integrated systems to the medtech, medical device and diagnostics industries through its sales force and global distribution channels. Both companies will be at the Medica tradeshow in Düsseldorf, Germany on November 14 - 17, 2016. Visit Ginolis Ltd in Hall 1 stand B15 and FocalSpec in Hall 8a stand N35.


Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.